Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

5.52
Delayed Data
As of Feb 12
 +0.63 / +12.88%
Today’s Change
4.25
Today|||52-Week Range
26.80
-36.62%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close4.89
Today’s open4.92
Day’s range4.87 - 5.60
Volume612,442
Average volume (3 months)443,290
Market cap$208.5M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+10.96%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+731.25%
P/E ratioNM
Price/Sales70.24
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...+0.02+2.27%
INNLInnocoll AG+0.79+9.64%
CARACara Therapeutics In...+0.25+3.47%
HSKAHeska Corp0.000.00%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.93
Annual revenue (last year)$3.8M
Annual profit (last year)-$34.7M
Net profit margin-906.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Operating Officer &
Executive Vice President
Jeffrey Su
Corporate headquarters
San Diego, California

Forecasts

Partner Offers